CLTS (Earth Life Sciences) EV-to-EBIT: 0.00 (As of Sep. 10, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CLTS Earth Life Sciences Inc CLTS
12 GF Score
Price $0.00
View Full Analysis

What is Earth Life Sciences EV-to-EBIT?

Earth Life Sciences CLTS -99.00% 12 EV-to-EBIT is 0.00 as of Sep. 10, 2026. GuruFocus rates CLTS with a GF Score™ of 12/100.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Earth Life Sciences's Enterprise Value is $0.00 Mil. Earth Life Sciences's EBIT for the trailing twelve months (TTM) ended in Sep. 2022 was $-0.35 Mil. Therefore, Earth Life Sciences's EV-to-EBIT for today is 0.00.

The historical rank and industry rank for Earth Life Sciences's EV-to-EBIT or its related term are showing as below:

CLTS's EV-to-EBIT is not ranked *
in the Software industry.
Industry Median: 13.66
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Earth Life Sciences's Enterprise Value for the quarter that ended in Sep. 2022 was $6.77 Mil. Earth Life Sciences's EBIT for the trailing twelve months (TTM) ended in Sep. 2022 was $-0.35 Mil. Earth Life Sciences's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2022 was -5.16%.


Earth Life Sciences  (OTCPK:CLTS) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Earth Life Sciences's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2022 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Sep. 2022 ) =EBIT / Enterprise Value (Q: Sep. 2022 )
=-0.349/6.767298
=-5.16 %

Earth Life Sciences's Enterprise Value for the quarter that ended in Sep. 2022 was $6.77 Mil.
Earth Life Sciences's EBIT for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.35 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Earth Life Sciences EV-to-EBIT Related Terms


Earth Life Sciences EV-to-EBIT Historical Data

* Premium members only.

The historical data trend for Earth Life Sciences's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Earth Life Sciences EV-to-EBIT Chart

Earth Life Sciences Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -139.73 -7.67 -66.84 -3.36 -4.12

Earth Life Sciences Quarterly Data
Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Jun22 Sep22
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.56 -6.79 -4.12 -30.73 -19.39

CLTS vs IMCI, CRCW, SSFT: EV-to-EBIT Comparison

For the Information Technology Services subindustry, Earth Life Sciences's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Earth Life Sciences EV-to-EBIT vs Software Industry

For the Software industry and Technology sector, Earth Life Sciences's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Earth Life Sciences's EV-to-EBIT falls into.


CLTS
12GF Score
Earth Life Sciences Inc CLTS
EV-to-EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Earth Life Sciences EV-to-EBIT Calculation

Earth Life Sciences's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=0.000/-0.349
=0.00

Earth Life Sciences's current Enterprise Value is $0.00 Mil.
Earth Life Sciences's EBIT for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.35 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EV-to-EBIT →
What does a EV-to-EBIT of 0.00 mean?
Earth Life Sciences (CLTS) has a EV-to-EBIT of 0.00 as of Sep. 10, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Earth Life Sciences and its competitors.
Is Earth Life Sciences' EV-to-EBIT too high?
Earth Life Sciences' current EV-to-EBIT is 0.00. Overall, Earth Life Sciences has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Earth Life Sciences' EV-to-EBIT compare to IMCI and CRCW?
Earth Life Sciences' EV-to-EBIT of 0.00 can be compared against companies in the Software industry. The industry median EV-to-EBIT is 13.66. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Software company?
The median EV-to-EBIT among Software companies is 13.66, based on 1,767 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Earth Life Sciences and its competitors. For the Software industry, the median EV-to-EBIT is 13.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Earth Life Sciences's current EV-to-EBIT is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Earth Life Sciences stock overvalued right now?
Earth Life Sciences (CLTS) has a current EV-to-EBIT of 0.00. The current EV-to-EBIT is 0.00. Earth Life Sciences' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Earth Life Sciences (CLTS), the current EV-to-EBIT is 0.00 as of Sep. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Earth Life Sciences Business Description

Address 50 West Liberty Street, Suite 880, Reno, NV, USA, 89501
Earth Life Sciences Inc offers Artificial Intelligence (AI)-driven mileage-based loyalty system for public transportation. The Miltean's AI platform enables an increase of ridership, decongestion analysis, interruption of service compensation, congestion management, prediction and analysis of ridership usage patterns. The firm caters to public traffic management systems and team up relationships between private and public enterprise.
12GF Score

Get the complete analysis for CLTS

EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price